DrugPatentWatch Database Preview
XOLAIR Drug Profile
Summary for Tradename: XOLAIR
Patents: | 91 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Pharmacology for XOLAIR
Mechanism of Action | IgE-directed Antibody Interactions |
Physiological Effect | Decreased IgE Activity |
US Patents for XOLAIR
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | ATOPIX THERAPEUTICS LIMITED (London, GB) | ➤ Sign Up | RX | search | |
Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | RX | search | |
Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | Knopp Biosciences LLC (Pittsburgh, PA) | ➤ Sign Up | RX | search | |
Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for XOLAIR
Country | Document Number | Estimated Expiration |
---|---|---|
Japan | 5268904 | ➤ Sign Up |
Canada | 2814040 | ➤ Sign Up |
European Patent Office | 1943204 | ➤ Sign Up |
Denmark | 2154223 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for XOLAIR
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
93138 | Luxembourg | ➤ Sign Up | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
92780 | Luxembourg | ➤ Sign Up | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
CA 2016 00031 | Denmark | ➤ Sign Up | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: EU/1/98/067 20140326 |
PA2015031 | Lithuania | ➤ Sign Up | PRODUCT NAME: TRASTUZUMABAS IR REKOMBINANTINE ZMOGAUS HIALURONIDAZE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |